Overview

Price chart · mood · technical indicators

ASRT

Assertio Therapeutics Incstock Healthcare

Drug Manufacturers - Specialty & Generic

$21.61136.17%Current Market Mood:Strong Bullish

Market Mood

Price Range (1Y)

$8.61$21.71

Current: $21.61

Market Comparison

vs Healthcare Sector & Drug Manufacturers - Specialty & Generic Industry

ASRT

+136.17%

1Y Performance

Healthcare

Sector 1Y

Drug Manufacturers - Specialty & Generic

Industry 1Y

Fundamentals

Updated daily after market close

P/E ratio—Forward 625.00

EPS (TTM)$-4.74-18.8% YoY

Profit margin-25.6%HEALTHCARE

Market cap$119.2MMicro cap

Wall Street coverage

$21.33median target· current $18.30 (+16.6%)4 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E: 625.00
PEG ratio: 1.50
P/B: 1.27
P/S (TTM): 1.00
EV/EBITDA: 35.96

Profitability & growth

ROE (TTM): -28.2%
Operating margin: -105.2%
Revenue growth YoY: -57.9%
Dividend yield: —
Beta: 0.43

Last earnings

Mar 11, 2026 · Estimate $-0.07 · Reported $-1.06

Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

50 articles · sorted by date

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Assertio Therapeutics Inc

Company profile

Assertio Holdings, Inc., a commercial pharmaceutical company, provides medications in the areas of neurology, hospital, and pain and inflammation. The company is headquartered in Lake Forest, Illinois.

Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: NASDAQ
Country: USA
Currency: USD

Company profile

HQ: 100 SOUTH SAUNDERS ROAD, LAKE FOREST, IL
Fiscal year end: December
Latest quarter: Dec 31, 2025

Market cap$119.2M

Shares outstanding$6.5M

52W high$20.45

52W low$8.61

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer

Overview

ASRT

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

Assertio parlays competing offer into $26 million bump for take-private deal

Assertio Amends Merger Agreement With Garda Therapeutics, Raises Takeover Price to $21.80 Per Share

Assertio Holdings to Be Acquired by Garda Therapeutics for $21.80 Per Share in All-Cash Deal, Reflecting 21% Premium 12

Assertio Agrees to Enhanced All-Cash Acquisition by Garda

Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics

Garda to acquire Assertio (NASDAQ: ASRT) for $21.80 cash per share

ASRT: Takeover Agreement And CVR Structure Will Support Future Repricing Potential

Assertio Holdings (ASRT) price target decreased by 28.76% to 27.80

Assertio and Garda Mutually Agree to Extend Tender Offer Deadline

Assertio Extends Garda Tender Offer Commencement Deadline

Garda to buy Assertio (NASDAQ: ASRT) for $18 per share in cash

Assertio Holdings (ASRT) price target decreased by 28.76% to 27.80

Assertio Deadline Reminder

Cosette acquires seven branded drugs from Assertio for $48.9M By Investing.com

Assertio Holdings Inc (NASDAQ: ASRT) recently announced it has reached a definitive acquisition agreement with Gardas.

Garda to launch $18 cash tender for Assertio (NASDAQ: ASRT) in April

Assertio to Face Tender Offer by Garda at $18.00/Share; Total Cash Consideration $125.1M

After window-shop ends, Garda plans $18-a-share Assertio tender

Assertio Holdings Inc (NASDAQ: ASRT) recently announced it has reached a definitive acquisition agreement with Gardas.

Assertio Provides Update on Garda Therapeutics Tender Process

About Assertio Therapeutics Inc

Classification

Company profile

ASRT

Market Comparison

ASRT Market Analysis

Overview

ASRT

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

Assertio parlays competing offer into $26 million bump for take-private deal

Assertio Amends Merger Agreement With Garda Therapeutics, Raises Takeover Price to $21.80 Per Share

Assertio Holdings to Be Acquired by Garda Therapeutics for $21.80 Per Share in All-Cash Deal, Reflecting 21% Premium 12

Assertio Agrees to Enhanced All-Cash Acquisition by Garda

Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics

Garda to acquire Assertio (NASDAQ: ASRT) for $21.80 cash per share

ASRT: Takeover Agreement And CVR Structure Will Support Future Repricing Potential

Assertio Holdings (ASRT) price target decreased by 28.76% to 27.80

Assertio and Garda Mutually Agree to Extend Tender Offer Deadline

Assertio Extends Garda Tender Offer Commencement Deadline

Garda to buy Assertio (NASDAQ: ASRT) for $18 per share in cash

Assertio Holdings (ASRT) price target decreased by 28.76% to 27.80

Assertio Deadline Reminder

Cosette acquires seven branded drugs from Assertio for $48.9M By Investing.com

Assertio Holdings Inc (NASDAQ: ASRT) recently announced it has reached a definitive acquisition agreement with Gardas.

Garda to launch $18 cash tender for Assertio (NASDAQ: ASRT) in April

Assertio to Face Tender Offer by Garda at $18.00/Share; Total Cash Consideration $125.1M

After window-shop ends, Garda plans $18-a-share Assertio tender

Assertio Holdings Inc (NASDAQ: ASRT) recently announced it has reached a definitive acquisition agreement with Gardas.

Assertio Provides Update on Garda Therapeutics Tender Process

About Assertio Therapeutics Inc

Classification

Company profile

ASRT

Market Comparison